The tariff classification of Aflibercept (CAS-862111-32-8) and EYLEA® Injection from Germany
Reasoning
The tariff classification of Aflibercept (CAS-862111-32-8) and EYLEA® Injection from Germany
Cite this ruling
CBP Ruling N243013 (3002100290): The tariff classification of Aflibercept (CAS-862111-32-8) and EYLEA® Injection from Germany
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300210
The tariff classification of various Roche laboratory reagents as calibrators and controls for clinical chemistry analyzers
Modification of New York Ruling Letter K83509; classification of monoclonal antibody medicaments
Modification of New York Ruling Letter K83806; classification of monoclonal antibody medicaments
Revocation of New York Ruling Letter H85059; classification of monoclonal antibody medicaments
Revocation of New York Ruling Letter K86861; classification of monoclonal antibody medicaments